日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Comprehensive analysis of the PLXNA3 gene on prognosis and immune characteristics in breast cancer

更正:PLXNA3基因在乳腺癌预后和免疫特征方面的综合分析

Sun, Wen; Xu, Yifan; Qi, Qi; Zhang, Weiya; Pan, Hong; Sun, Guangshun; Wang, Shui; Zhou, Wenbin

Assessment of coastal land use structure and efficiency based on multi-source data: From the perspective of sea-land gradient

基于多源数据的沿海土地利用结构及效率评价:从海陆梯度视角出发

Pei, Yifei; Zhu, Jianfeng; Zhou, Jiake; Sun, Guangshun; Tang, Shiru

Comprehensive analysis of the PLXNA3 gene on prognosis and immune characteristics in breast cancer

PLXNA3基因在乳腺癌预后和免疫特征中的综合分析

Sun, Wen; Xu, Yifan; Qi, Qi; Zhang, Weiya; Pan, Hong; Sun, Guangshun; Wang, Shui; Zhou, Wenbin

Correction: Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer

更正:乳腺癌中过氧化物酶表达谱及其预后价值的综合分析

Mei, Jie; Hao, Leiyu; Liu, Xiaorui; Sun, Guangshun; Xu, Rui; Wang, Huiyu; Liu, Chaoying

GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway

GLIS1 干预通过靶向 SGK1-STAT3-PD1 通路增强抗 PD-1 疗法治疗肝细胞癌的效果。

Rong, Dawei; Wang, Yuliang; Liu, Li; Cao, Hengsong; Huang, Tian; Liu, Hanyuan; Hao, Xiaopei; Sun, Guangshun; Sun, Guoqiang; Zheng, Zhiying; Kang, Junwei; Xia, Yongxiang; Chen, Ziyi; Tang, Weiwei; Wang, Xuehao

Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing

基于单细胞RNA测序的研究表明,APOC1抑制剂可通过铁死亡途径促进M2型巨噬细胞向M1型巨噬细胞转化,并增强抗PD-1免疫疗法在肝细胞癌中的疗效。

Hao, Xiaopei; Zheng, Zhiying; Liu, Hanyuan; Zhang, Yao; Kang, Junwei; Kong, Xiangyi; Rong, Dawei; Sun, Guangshun; Sun, Guoqiang; Liu, Li; Yu, Haibo; Tang, Weiwei; Wang, Xuehao

Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy

巨噬细胞 GSK3β 缺陷可抑制肝细胞癌的进展并增强抗 PD-1 免疫疗法的敏感性

Sun, Guangshun; Liu, Hanyuan; Zhao, Jie; Zhang, Jinyu; Huang, Tian; Sun, Guoqiang; Zhao, Siqi; Zhang, Zihao; Cao, Hengsong; Rong, Dawei; Kong, Xiangyi; Ji, Qinghua; Liu, Li; Wang, Xuehao; Tang, Weiwei; Xia, Yongxiang

Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies

肿瘤微环境及其对胆管癌抗肿瘤免疫的影响:新型疗法的未来展望

Cao, Hengsong; Huang, Tian; Dai, Mingrui; Kong, Xiangyi; Liu, Hanyuan; Zheng, Zhiying; Sun, Guoqiang; Sun, Guangshun; Rong, Dawei; Jin, Zehua; Tang, Weiwei; Xia, Yongxiang

Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma.

GUSB 过度表达导致肝细胞癌对 PD-1 抑制剂产生原发性耐药

Kong Xiangyi, Zheng Zhiying, Song Guoxin, Zhang Zihao, Liu Hanyuan, Kang Junwei, Sun Guoqiang, Sun Guangshun, Huang Tian, Li Xiao, Rong Dawei, Wang Ke, Tang Weiwei, Xia Yongxiang

Treatment of patients with cancer using PD‑1/PD‑L1 antibodies: Adverse effects and management strategies (Review)

使用 PD-1/PD-L1 抗体治疗癌症患者:不良反应及管理策略(综述)

Sun, Guangshun; Liu, Hanyuan; Shi, Xuesong; Tan, Pengyu; Tang, Weiwei; Chen, Xin; Sun, Guoqiang; Yang, Weijun; Kong, Xiangyi; Zheng, Zhiying; Cao, Hongyong; Shao, Guoqiang